
Sign up to save your podcasts
Or
In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson’s in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer’s.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson’s in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer’s.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
129 Listeners
7,899 Listeners
273 Listeners
313 Listeners
35 Listeners
488 Listeners
13 Listeners
169 Listeners
506 Listeners
131 Listeners
317 Listeners
176 Listeners
365 Listeners
2 Listeners
75 Listeners